> top > docs > PubMed:22966071 > annotations

PubMed:22966071 JSONTXT

Annnotations TAB JSON ListView MergeView

sonoma2

Id Subject Object Predicate Lexical cue
T0 0-44 GENE denotes Sterol regulatory element-binding protein-1c
T1 0-44 GENE denotes Sterol regulatory element-binding protein-1c
T2 54-62 POSREG denotes increase
T3 66-91 MPA denotes postprandial stearic acid
T4 105-111 MPA denotes target
T5 116-125 POSREG denotes improving
T6 126-144 MPA denotes insulin resistance
T7 126-133 GENE denotes insulin
T8 149-163 MPA denotes hyperlipidemia
T9 149-163 DISEASE denotes hyperlipidemia
T10 165-173 POSREG denotes Elevated
T11 174-196 MPA denotes serum free fatty acids
T12 198-202 MPA denotes FFAs
T13 204-210 MPA denotes levels
T14 211-215 REG denotes play
T15 229-233 REG denotes role
T16 256-274 MPA denotes insulin resistance
T17 256-263 GENE denotes insulin
T18 276-278 MPA denotes IR
T19 284-292 DISEASE denotes diabetes
T20 386-397 MPA denotes FFA profile
T21 401-415 MPA denotes hyperlipidemia
T22 401-415 DISEASE denotes hyperlipidemia
T23 417-420 MPA denotes HLP
T24 432-440 REG denotes relation
T25 446-465 MPA denotes insulin sensitivity
T26 446-453 GENE denotes insulin
T27 505-523 MPA denotes serum stearic acid
T28 525-527 MPA denotes SA
T29 541-551 MPA denotes fatty acid
T30 560-569 POSREG denotes increased
T31 590-602 MPA denotes postprandial
T32 614-623 POSREG denotes elevation
T33 627-629 MPA denotes SA
T34 633-636 REG denotes due
T35 640-649 POSREG denotes increased
T36 650-686 MPA denotes insulin-stimulated de novo synthesis
T37 650-668 GENE denotes insulin-stimulated
T38 687-695 REG denotes mediated
T39 699-743 GENE denotes sterol regulatory element-binding protein-1c
T40 744-765 GENE denotes (SREBP-1c)/acetyl-CoA
T41 744-765 GENE denotes (SREBP-1c)/acetyl-CoA
T42 766-808 GENE denotes carboxylase/fatty acid synthase/elongation
T43 784-808 GENE denotes acid synthase/elongation
T44 851-857 GENE denotes ELOVL6
T45 851-857 GENE denotes ELOVL6
T46 867-877 POSREG denotes elongation
T47 881-894 MPA denotes palmitic acid
T48 896-898 MPA denotes PA
T49 900-909 REG denotes catalyzed
T50 913-919 GENE denotes ELOVL6
T51 913-919 GENE denotes ELOVL6
T52 921-935 NEGREG denotes Downregulation
T53 939-947 GENE denotes SREBP-1c
T54 951-957 GENE denotes ELOVL6
T55 961-982 MPA denotes small interfering RNA
T56 987-993 NEGREG denotes reduce
T57 994-1006 MPA denotes SA synthesis
T58 1020-1034 MPA denotes serum SA level
T59 1048-1060 POSREG denotes amelioration
T60 1064-1066 MPA denotes IR
T61 1070-1073 MPA denotes HLP
T62 1089-1099 NEGREG denotes inhibition
T63 1103-1111 GENE denotes SREBP-1c
T64 1133-1142 POSREG denotes improving
T65 1143-1145 MPA denotes IR
T66 1151-1162 NEGREG denotes suppression
T67 1166-1172 GENE denotes ELOVL6
T68 1192-1204 POSREG denotes accumulation
T69 1208-1210 MPA denotes PA
T70 1224-1233 POSREG denotes increased
T71 1234-1249 MPA denotes postprandial SA
T72 1253-1259 REG denotes caused
T73 1267-1285 POSREG denotes insulin-stimulated
T74 1267-1285 GENE denotes insulin-stimulated
T75 1286-1294 GENE denotes SREBP-1c
T76 1286-1294 GENE denotes SREBP-1c
T77 1295-1302 MPA denotes pathway
T78 1307-1317 POSREG denotes elongation
T79 1321-1323 MPA denotes PA
T80 1327-1330 MPA denotes HLP
T81 1332-1341 NEGREG denotes Reduction
T82 1345-1360 MPA denotes postprandial SA
T83 1371-1380 MPA denotes candidate
T84 1385-1394 POSREG denotes improving
T85 1395-1397 MPA denotes IR
T86 1403-1411 GENE denotes SREBP-1c
T87 1403-1411 GENE denotes SREBP-1c
T88 1436-1442 MPA denotes target
T89 1454-1456 MPA denotes IR
T90 1461-1469 DISEASE denotes diabetes
T91 1473-1483 NEGREG denotes decreasing
T92 1484-1486 MPA denotes SA
R70 T47 T49 ThemeOf palmitic acid,catalyzed
R71 T48 T38 ThemeOf PA,mediated
R0 T0 T2 CauseOf Sterol regulatory element-binding protein-1c,increase
R1 T0 T5 CauseOf Sterol regulatory element-binding protein-1c,improving
R2 T2 T5 CauseOf increase,improving
R3 T3 T2 ThemeOf postprandial stearic acid,increase
R4 T3 T4 ThemeOf postprandial stearic acid,target
R5 T4 T2 ThemeOf target,increase
R6 T4 T5 CauseOf target,improving
R7 T6 T4 ThemeOf insulin resistance,target
R8 T6 T5 ThemeOf insulin resistance,improving
R9 T8 T2 ThemeOf hyperlipidemia,increase
R10 T8 T4 ThemeOf hyperlipidemia,target
R11 T8 T5 ThemeOf hyperlipidemia,improving
R12 T10 T14 CauseOf Elevated,play
R13 T10 T15 CauseOf Elevated,role
R14 T11 T10 ThemeOf serum free fatty acids,Elevated
R15 T11 T13 ThemeOf serum free fatty acids,levels
R16 T11 T14 ThemeOf serum free fatty acids,play
R17 T12 T10 ThemeOf FFAs,Elevated
R18 T12 T13 ThemeOf FFAs,levels
R19 T12 T14 ThemeOf FFAs,play
R20 T13 T10 ThemeOf levels,Elevated
R21 T13 T14 ThemeOf levels,play
R22 T13 T15 ThemeOf levels,role
R23 T16 T14 ThemeOf insulin resistance,play
R24 T16 T15 ThemeOf insulin resistance,role
R25 T16 T18 ThemeOf insulin resistance,IR
R26 T18 T14 ThemeOf IR,play
R27 T18 T15 ThemeOf IR,role
R28 T19 T14 ThemeOf diabetes,play
R29 T19 T15 ThemeOf diabetes,role
R30 T19 T16 ThemeOf diabetes,insulin resistance
R31 T21 T20 ThemeOf hyperlipidemia,FFA profile
R32 T23 T20 ThemeOf HLP,FFA profile
R33 T20 T24 ThemeOf FFA profile,relation
R34 T21 T23 ThemeOf hyperlipidemia,HLP
R35 T21 T24 ThemeOf hyperlipidemia,relation
R36 T23 T24 ThemeOf HLP,relation
R37 T25 T24 ThemeOf insulin sensitivity,relation
R38 T27 T28 ThemeOf serum stearic acid,SA
R39 T27 T29 ThemeOf serum stearic acid,fatty acid
R40 T27 T30 ThemeOf serum stearic acid,increased
R41 T28 T29 ThemeOf SA,fatty acid
R42 T28 T30 ThemeOf SA,increased
R43 T29 T30 ThemeOf fatty acid,increased
R44 T31 T30 ThemeOf postprandial,increased
R45 T32 T34 ThemeOf elevation,due
R46 T32 T35 CauseOf elevation,increased
R47 T32 T46 CauseOf elevation,elongation
R48 T33 T32 ThemeOf SA,elevation
R49 T33 T34 ThemeOf SA,due
R50 T33 T35 CauseOf SA,increased
R51 T35 T34 CauseOf increased,due
R52 T35 T38 CauseOf increased,mediated
R53 T35 T46 CauseOf increased,elongation
R54 T36 T35 ThemeOf insulin-stimulated de novo synthesis,increased
R55 T36 T38 ThemeOf insulin-stimulated de novo synthesis,mediated
R56 T40 T32 CauseOf (SREBP-1c)/acetyl-CoA,elevation
R57 T40 T35 CauseOf (SREBP-1c)/acetyl-CoA,increased
R58 T40 T38 ThemeOf (SREBP-1c)/acetyl-CoA,mediated
R59 T40 T46 CauseOf (SREBP-1c)/acetyl-CoA,elongation
R60 T43 T32 CauseOf acid synthase/elongation,elevation
R61 T43 T35 CauseOf acid synthase/elongation,increased
R62 T43 T38 ThemeOf acid synthase/elongation,mediated
R63 T43 T46 CauseOf acid synthase/elongation,elongation
R64 T44 T32 CauseOf ELOVL6,elevation
R65 T44 T35 CauseOf ELOVL6,increased
R66 T44 T38 ThemeOf ELOVL6,mediated
R67 T44 T46 CauseOf ELOVL6,elongation
R68 T47 T38 ThemeOf palmitic acid,mediated
R69 T47 T46 ThemeOf palmitic acid,elongation
R72 T48 T46 ThemeOf PA,elongation
R73 T48 T49 ThemeOf PA,catalyzed
R74 T50 T46 CauseOf ELOVL6,elongation
R75 T50 T49 ThemeOf ELOVL6,catalyzed
R76 T52 T35 CauseOf Downregulation,increased
R77 T52 T46 CauseOf Downregulation,elongation
R78 T52 T56 CauseOf Downregulation,reduce
R79 T52 T59 CauseOf Downregulation,amelioration
R80 T53 T52 ThemeOf SREBP-1c,Downregulation
R81 T53 T55 ThemeOf SREBP-1c,small interfering RNA
R82 T54 T52 ThemeOf ELOVL6,Downregulation
R83 T55 T52 CauseOf small interfering RNA,Downregulation
R84 T55 T56 CauseOf small interfering RNA,reduce
R85 T55 T59 CauseOf small interfering RNA,amelioration
R86 T56 T59 CauseOf reduce,amelioration
R87 T57 T56 ThemeOf SA synthesis,reduce
R88 T58 T56 ThemeOf serum SA level,reduce
R89 T60 T59 ThemeOf IR,amelioration
R90 T61 T60 ThemeOf HLP,IR
R91 T61 T59 ThemeOf HLP,amelioration
R92 T62 T59 CauseOf inhibition,amelioration
R93 T62 T64 CauseOf inhibition,improving
R94 T62 T66 CauseOf inhibition,suppression
R95 T62 T68 CauseOf inhibition,accumulation
R96 T63 T62 ThemeOf SREBP-1c,inhibition
R97 T64 T68 CauseOf improving,accumulation
R98 T65 T64 ThemeOf IR,improving
R99 T66 T64 CauseOf suppression,improving
R100 T66 T68 CauseOf suppression,accumulation
R101 T67 T66 ThemeOf ELOVL6,suppression
R102 T69 T68 ThemeOf PA,accumulation
R103 T70 T72 CauseOf increased,caused
R104 T70 T78 CauseOf increased,elongation
R105 T71 T70 ThemeOf postprandial SA,increased
R106 T71 T72 ThemeOf postprandial SA,caused
R107 T73 T70 CauseOf insulin-stimulated,increased
R108 T73 T72 CauseOf insulin-stimulated,caused
R109 T77 T73 ThemeOf pathway,insulin-stimulated
R110 T73 T78 CauseOf insulin-stimulated,elongation
R111 T75 T73 ThemeOf SREBP-1c,insulin-stimulated
R112 T75 T77 ThemeOf SREBP-1c,pathway
R113 T78 T72 CauseOf elongation,caused
R114 T79 T78 ThemeOf PA,elongation
R115 T80 T79 ThemeOf HLP,PA
R116 T80 T72 ThemeOf HLP,caused
R117 T80 T73 ThemeOf HLP,insulin-stimulated
R118 T80 T78 ThemeOf HLP,elongation
R119 T81 T84 CauseOf Reduction,improving
R120 T91 T81 CauseOf decreasing,Reduction
R121 T82 T81 ThemeOf postprandial SA,Reduction
R122 T82 T83 ThemeOf postprandial SA,candidate
R123 T82 T84 ThemeOf postprandial SA,improving
R124 T83 T84 CauseOf candidate,improving
R125 T91 T84 CauseOf decreasing,improving
R126 T85 T84 ThemeOf IR,improving
R127 T85 T88 ThemeOf IR,target
R128 T86 T88 ThemeOf SREBP-1c,target
R129 T88 T84 CauseOf target,improving
R130 T89 T88 ThemeOf IR,target
R131 T89 T91 ThemeOf IR,decreasing
R132 T90 T81 ThemeOf diabetes,Reduction
R133 T90 T84 ThemeOf diabetes,improving
R134 T90 T88 ThemeOf diabetes,target
R135 T90 T91 ThemeOf diabetes,decreasing
R136 T92 T91 ThemeOf SA,decreasing

sonoma

Id Subject Object Predicate Lexical cue
T-0 0-44 GENE denotes Sterol regulatory element-binding protein-1c
T-1 54-62 POSREG denotes increase
T-2 66-91 MPA denotes postprandial stearic acid
T-3 116-125 POSREG denotes improving
T-4 126-144 MPA denotes insulin resistance
T-5 149-163 MPA denotes hyperlipidemia
T-6 165-173 POSREG denotes Elevated
T-7 174-203 MPA denotes serum free fatty acids (FFAs)
T-8 219-233 REG denotes important role
T-9 256-274 MPA denotes insulin resistance
T-10 276-278 MPA denotes IR
T-11 284-292 DISEASE denotes diabetes
T-12 386-389 MPA denotes FFA
T-13 401-421 MPA denotes hyperlipidemia (HLP)
T-14 446-465 MPA denotes insulin sensitivity
T-15 505-528 MPA denotes serum stearic acid (SA)
T-16 560-569 POSREG denotes increased
T-17 614-623 POSREG denotes elevation
T-18 627-629 MPA denotes SA
T-19 633-636 REG denotes due
T-20 640-649 POSREG denotes increased
T-21 650-686 MPA denotes insulin-stimulated de novo synthesis
T-22 717-858 PATHWAY denotes element-binding protein-1c (SREBP-1c)/acetyl-CoA carboxylase/fatty acid synthase/elongation of long-chain fatty acid family member 6 (ELOVL6)
T-23 867-877 POSREG denotes elongation
T-24 881-894 MPA denotes palmitic acid
T-25 896-898 MPA denotes PA
T-26 913-919 GENE denotes ELOVL6
T-27 921-935 NEGREG denotes Downregulation
T-28 939-947 GENE denotes SREBP-1c
T-29 951-957 GENE denotes ELOVL6
T-30 961-982 MPA denotes small interfering RNA
T-31 987-993 NEGREG denotes reduce
T-32 994-1006 MPA denotes SA synthesis
T-33 1026-1034 MPA denotes SA level
T-34 1048-1060 POSREG denotes amelioration
T-35 1064-1066 MPA denotes IR
T-36 1070-1073 MPA denotes HLP
T-37 1089-1099 NEGREG denotes inhibition
T-38 1103-1111 GENE denotes SREBP-1c
T-39 1133-1142 POSREG denotes improving
T-40 1143-1145 MPA denotes IR
T-41 1151-1162 NEGREG denotes suppression
T-42 1166-1172 GENE denotes ELOVL6
T-43 1180-1188 REG denotes resulted
T-44 1192-1210 MPA denotes accumulation of PA
T-45 1224-1233 POSREG denotes increased
T-46 1247-1249 MPA denotes SA
T-47 1253-1259 REG denotes caused
T-48 1286-1302 PATHWAY denotes SREBP-1c pathway
T-49 1307-1317 POSREG denotes elongation
T-50 1321-1323 MPA denotes PA
T-51 1327-1330 MPA denotes HLP
T-52 1332-1341 NEGREG denotes Reduction
T-53 1358-1360 MPA denotes SA
T-54 1385-1394 POSREG denotes improving
T-55 1395-1397 MPA denotes IR
T-56 1403-1411 GENE denotes SREBP-1c
T-57 1429-1442 POSREG denotes better target
T-58 1454-1456 MPA denotes IR
T-59 1461-1469 DISEASE denotes diabetes
T-60 1473-1483 NEGREG denotes decreasing
T-61 1484-1486 MPA denotes SA
R-13 T-17 T-19 ThemeOf elevation,due
R-14 T-49 T-47 CauseOf elongation,caused
R-15 T-49 T-45 ThemeOf elongation,increased
R-16 T-50 T-49 ThemeOf PA,elongation
R-17 T-52 T-54 CauseOf Reduction,improving
R-18 T-53 T-52 ThemeOf SA,Reduction
R-19 T-53 T-54 ThemeOf SA,improving
R-20 T-58 T-60 ThemeOf IR,decreasing
R-21 T-58 T-57 ThemeOf IR,better target
R-22 T-61 T-60 ThemeOf SA,decreasing
R-23 T-26 T-23 ThemeOf ELOVL6,elongation
R-24 T-20 T-19 CauseOf increased,due
R-25 T-20 T-17 CauseOf increased,elevation
R-26 T-0 T-1 ThemeOf Sterol regulatory element-binding protein-1c,increase
R-27 T-0 T-2 CauseOf Sterol regulatory element-binding protein-1c,postprandial stearic acid
R-28 T-0 T-4 CauseOf Sterol regulatory element-binding protein-1c,insulin resistance
R-29 T-4 T-3 ThemeOf insulin resistance,improving
R-30 T-5 T-4 ThemeOf hyperlipidemia,insulin resistance
R-31 T-7 T-6 ThemeOf serum free fatty acids (FFAs),Elevated
R-32 T-7 T-8 ThemeOf serum free fatty acids (FFAs),important role
R-33 T-8 T-9 ThemeOf important role,insulin resistance
R-34 T-8 T-10 ThemeOf important role,IR
R-35 T-8 T-11 ThemeOf important role,diabetes
R-36 T-27 T-34 CauseOf Downregulation,amelioration
R-37 T-27 T-31 CauseOf Downregulation,reduce
R-38 T-13 T-12 ThemeOf hyperlipidemia (HLP),FFA
R-39 T-14 T-12 ThemeOf insulin sensitivity,FFA
R-40 T-21 T-20 ThemeOf insulin-stimulated de novo synthesis,increased
R-41 T-24 T-23 ThemeOf palmitic acid,elongation
R-42 T-25 T-23 ThemeOf PA,elongation
R-43 T-23 T-17 CauseOf elongation,elevation
R-44 T-30 T-27 CauseOf small interfering RNA,Downregulation
R-45 T-32 T-31 ThemeOf SA synthesis,reduce
R-53 T-51 T-50 ThemeOf HLP,PA
R-54 T-55 T-54 ThemeOf IR,improving
R-55 T-56 T-57 ThemeOf SREBP-1c,better target
R-56 T-56 T-60 CauseOf SREBP-1c,decreasing
R-57 T-28 T-27 ThemeOf SREBP-1c,Downregulation
R-58 T-29 T-27 ThemeOf ELOVL6,Downregulation
R-59 T-35 T-34 ThemeOf IR,amelioration
R-60 T-36 T-34 ThemeOf HLP,amelioration
R-61 T-59 T-57 ThemeOf diabetes,better target
R-62 T-59 T-60 ThemeOf diabetes,decreasing
R-0 T-2 T-1 ThemeOf postprandial stearic acid,increase
R-1 T-2 T-4 CauseOf postprandial stearic acid,insulin resistance
R-2 T-37 T-39 CauseOf inhibition,improving
R-3 T-37 T-43 CauseOf inhibition,resulted
R-4 T-18 T-17 ThemeOf SA,elevation
R-5 T-18 T-19 ThemeOf SA,due
R-6 T-38 T-37 ThemeOf SREBP-1c,inhibition
R-7 T-41 T-39 CauseOf suppression,improving
R-8 T-41 T-43 CauseOf suppression,resulted
R-9 T-42 T-41 ThemeOf ELOVL6,suppression
R-10 T-44 T-43 ThemeOf accumulation of PA,resulted
R-11 T-46 T-45 ThemeOf SA,increased
R-12 T-46 T-47 ThemeOf SA,caused
R-46 T-33 T-31 ThemeOf SA level,reduce
R-47 T-40 T-39 ThemeOf IR,improving
R-48 T-22 T-17 CauseOf element-binding protein-1c (SREBP-1c)/acetyl-CoA carboxylase/fatty acid synthase/elongation of long-chain fatty acid family member 6 (ELOVL6),elevation
R-49 T-22 T-19 CauseOf element-binding protein-1c (SREBP-1c)/acetyl-CoA carboxylase/fatty acid synthase/elongation of long-chain fatty acid family member 6 (ELOVL6),due
R-50 T-15 T-16 ThemeOf serum stearic acid (SA),increased
R-51 T-48 T-45 CauseOf SREBP-1c pathway,increased
R-52 T-48 T-47 CauseOf SREBP-1c pathway,caused

DisGeNET

Id Subject Object Predicate Lexical cue
T0 126-133 gene:3630 denotes insulin
T1 149-163 disease:C0020473 denotes hyperlipidemia
T2 126-133 gene:723961 denotes insulin
T3 149-163 disease:C0020473 denotes hyperlipidemia
T4 256-263 gene:723961 denotes insulin
T5 284-292 disease:C0011847 denotes diabetes
T6 256-263 gene:723961 denotes insulin
T7 284-292 disease:C0011849 denotes diabetes
T8 256-263 gene:3630 denotes insulin
T9 284-292 disease:C0011847 denotes diabetes
T10 256-263 gene:3630 denotes insulin
T11 284-292 disease:C0011849 denotes diabetes
T12 446-453 gene:723961 denotes insulin
T13 401-415 disease:C0020473 denotes hyperlipidemia
T14 446-453 gene:723961 denotes insulin
T15 417-420 disease:C0020473 denotes HLP
T16 446-453 gene:3630 denotes insulin
T17 401-415 disease:C0020473 denotes hyperlipidemia
T18 446-453 gene:3630 denotes insulin
T19 417-420 disease:C0020473 denotes HLP
T20 913-919 gene:79071 denotes ELOVL6
T21 640-657 disease:C0020459 denotes increased insulin
T22 699-740 gene:7555 denotes sterol regulatory element-binding protein
T23 640-657 disease:C0020459 denotes increased insulin
T24 851-857 gene:79071 denotes ELOVL6
T25 640-657 disease:C0020459 denotes increased insulin
T26 778-797 gene:2194 denotes fatty acid synthase
T27 640-657 disease:C0020459 denotes increased insulin
T28 745-753 gene:6720 denotes SREBP-1c
T29 640-657 disease:C0020459 denotes increased insulin
T30 1286-1294 gene:6720 denotes SREBP-1c
T31 1327-1330 disease:C0020473 denotes HLP
T32 1403-1411 gene:6720 denotes SREBP-1c
T33 1461-1469 disease:C0011847 denotes diabetes
T34 1403-1411 gene:6720 denotes SREBP-1c
T35 1461-1469 disease:C0011849 denotes diabetes
R1 T0 T1 associated_with insulin,hyperlipidemia
R2 T2 T3 associated_with insulin,hyperlipidemia
R3 T4 T5 associated_with insulin,diabetes
R4 T6 T7 associated_with insulin,diabetes
R5 T8 T9 associated_with insulin,diabetes
R6 T10 T11 associated_with insulin,diabetes
R7 T12 T13 associated_with insulin,hyperlipidemia
R8 T14 T15 associated_with insulin,HLP
R9 T16 T17 associated_with insulin,hyperlipidemia
R10 T18 T19 associated_with insulin,HLP
R11 T20 T21 associated_with ELOVL6,increased insulin
R12 T22 T23 associated_with sterol regulatory element-binding protein,increased insulin
R13 T24 T25 associated_with ELOVL6,increased insulin
R14 T26 T27 associated_with fatty acid synthase,increased insulin
R15 T28 T29 associated_with SREBP-1c,increased insulin
R16 T30 T31 associated_with SREBP-1c,HLP
R17 T32 T33 associated_with SREBP-1c,diabetes
R18 T34 T35 associated_with SREBP-1c,diabetes

Allie

Id Subject Object Predicate Lexical cue
SS1_22966071_1_0 180-196 expanded denotes free fatty acids
SS2_22966071_1_0 198-202 abbr denotes FFAs
SS1_22966071_1_1 256-274 expanded denotes insulin resistance
SS2_22966071_1_1 276-278 abbr denotes IR
SS1_22966071_2_0 401-415 expanded denotes hyperlipidemia
SS2_22966071_2_0 417-420 abbr denotes HLP
SS1_22966071_3_0 511-523 expanded denotes stearic acid
SS2_22966071_3_0 525-527 abbr denotes SA
SS1_22966071_4_0 699-743 expanded denotes sterol regulatory element-binding protein-1c
SS2_22966071_4_0 745-753 abbr denotes SREBP-1c
SS1_22966071_4_1 881-894 expanded denotes palmitic acid
SS2_22966071_4_1 896-898 abbr denotes PA
AE1_22966071_1_0 SS1_22966071_1_0 SS2_22966071_1_0 abbreviatedTo free fatty acids,FFAs
AE1_22966071_1_1 SS1_22966071_1_1 SS2_22966071_1_1 abbreviatedTo insulin resistance,IR
AE1_22966071_2_0 SS1_22966071_2_0 SS2_22966071_2_0 abbreviatedTo hyperlipidemia,HLP
AE1_22966071_3_0 SS1_22966071_3_0 SS2_22966071_3_0 abbreviatedTo stearic acid,SA
AE1_22966071_4_0 SS1_22966071_4_0 SS2_22966071_4_0 abbreviatedTo sterol regulatory element-binding protein-1c,SREBP-1c
AE1_22966071_4_1 SS1_22966071_4_1 SS2_22966071_4_1 abbreviatedTo palmitic acid,PA

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 256-274 HP_0000855 denotes insulin resistance
T2 401-415 HP_0003077 denotes hyperlipidemia

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
22966071-0#0#41#gene7555 0-41 gene7555 denotes Sterol regulatory element-binding protein
22966071-0#149#163#diseaseC0020473 149-163 diseaseC0020473 denotes hyperlipidemia
22966071-4#89#130#gene7555 699-740 gene7555 denotes sterol regulatory element-binding protein
22966071-4#135#143#gene6720 745-753 gene6720 denotes SREBP-1c
22966071-4#241#247#gene79071 851-857 gene79071 denotes ELOVL6
22966071-4#303#309#gene79071 913-919 gene79071 denotes ELOVL6
22966071-4#30#47#diseaseC0020459 640-657 diseaseC0020459 denotes increased insulin
22966071-7#74#82#gene6720 1286-1294 gene6720 denotes SREBP-1c
22966071-7#115#118#diseaseC0263420 1327-1330 diseaseC0263420 denotes HLP
22966071-8#71#79#gene6720 1403-1411 gene6720 denotes SREBP-1c
22966071-8#129#137#diseaseC0011847 1461-1469 diseaseC0011847 denotes diabetes
22966071-8#129#137#diseaseC0011849 1461-1469 diseaseC0011849 denotes diabetes
0#41#gene7555149#163#diseaseC0020473 22966071-0#0#41#gene7555 22966071-0#149#163#diseaseC0020473 associated_with Sterol regulatory element-binding protein,hyperlipidemia
89#130#gene755530#47#diseaseC0020459 22966071-4#89#130#gene7555 22966071-4#30#47#diseaseC0020459 associated_with sterol regulatory element-binding protein,increased insulin
135#143#gene672030#47#diseaseC0020459 22966071-4#135#143#gene6720 22966071-4#30#47#diseaseC0020459 associated_with SREBP-1c,increased insulin
241#247#gene7907130#47#diseaseC0020459 22966071-4#241#247#gene79071 22966071-4#30#47#diseaseC0020459 associated_with ELOVL6,increased insulin
303#309#gene7907130#47#diseaseC0020459 22966071-4#303#309#gene79071 22966071-4#30#47#diseaseC0020459 associated_with ELOVL6,increased insulin
74#82#gene6720115#118#diseaseC0263420 22966071-7#74#82#gene6720 22966071-7#115#118#diseaseC0263420 associated_with SREBP-1c,HLP
71#79#gene6720129#137#diseaseC0011847 22966071-8#71#79#gene6720 22966071-8#129#137#diseaseC0011847 associated_with SREBP-1c,diabetes
71#79#gene6720129#137#diseaseC0011849 22966071-8#71#79#gene6720 22966071-8#129#137#diseaseC0011849 associated_with SREBP-1c,diabetes